The Board of Directors of MAX Healthcare Institute Limited has approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. The consolidated revenue from operations reached ₹2,13,547 lakhs. The board’s decision, made on November 14, 2025, follows a review by the Audit Committee. These results reflect the company’s performance during Q2 2026.
Financial Performance Highlights
MAX Healthcare Institute Limited announced its unaudited consolidated financial results for Q2 2026, with key highlights including:
- Revenue from operations: ₹2,13,547 lakhs
- Total Income: ₹2,16,837 lakhs
- Profit before tax: ₹44,603 lakhs
- Profit for the period: ₹49,130 lakhs
Standalone Financial Results
The unaudited standalone financial results for Q2 2026 show:
- Revenue from operations: ₹73,662 lakhs
- Total Income: ₹78,405 lakhs
- Profit before tax: ₹21,566 lakhs
- Profit for the period: ₹16,042 lakhs
Subsidiaries and Divestments
The company divested hospitals located at village Chitta and Anoopshahr in district Bulandshahr (UP) on September 17, 2025, for a total consideration of ₹4,066 lakhs. This decision aligns with the company’s strategy to focus on super specialty hospitals in larger cities.
Merger and Acquisition
The merger of Crosslay Remedies Limited (CRL) with Jaypee Healthcare Limited (JHL) was approved by the National Company Law Tribunal (NCLT), effective October 5, 2024. This merger was accounted as business combinations under common control as per Ind AS 103.
Source: BSE
